Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial)

research Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).

4 citations , October 2020 in “Research Square (Research Square)”

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

research Androgenic alopecia. The main treatment options

November 2022 in “NATIONS UNIVERSITY INTERNATIONAL JOURNAL OF MULTI-DISCIPLINARY STUDIES”

Minoxidil and finasteride are common but limited treatments for hair loss, with new therapies showing promise.

research Prescribing Habits for Androgenic Alopecia among Dermatologists in Spain in 2019–2020: A Cross-Sectional Study

3 citations , January 2020 in “Skin appendage disorders”

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

research Dissolving microneedle patch loading dutasteride microspheres for the long-acting treatment of androgenetic alopecia

June 2025 in “Journal of Drug Delivery Science and Technology”

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

research Accelerated, injectable, self-healing, scarless wound dressings using rGO reinforced dextran/chitosan hydrogels incorporated with PDA-loaded asiaticoside

17 citations , August 2024 in “International Journal of Biological Macromolecules”

The hydrogel dressings speed up healing and reduce scarring.

research Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata

44 citations , October 2009 in “Journal of the American Academy of Dermatology”

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Penile Vascular Abnormalities in Young Men with Persistent Side Effects After Finasteride Use for the Treatment of Androgenic Alopecia

research Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia

7 citations , June 2020 in “Translational Andrology and Urology”

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

The Effect of an Oral Product Containing Amla Fruit on Female Androgenetic Alopecia: A Randomized Controlled Trial

research The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial

July 2023 in “Journal of Ethnopharmacology”

Amla fruit syrup improved hair growth and satisfaction in women with hair loss without significant side effects.

Among Scalp Non-Responder Patients with Eyebrow/Eyelash Regrowth in the First Year, Continued Treatment with Baricitinib Resulted in Meaningful Scalp Responses for Patients with Severe Alopecia Areata

research 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata

September 2024 in “Journal of the American Academy of Dermatology”

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

research Ann Robinson’s research reviews —12 May 2022

May 2022 in “The BMJ”

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

← Previous page